Daniel W. Muehl
2016 - Clovis Oncology
In 2016, Daniel W. Muehl earned a total compensation of $1.6M as Senior VP of Finance at Clovis Oncology.
Compensation breakdown
| Bonus | $170,799 |
|---|---|
| Option Awards | $824,799 |
| Salary | $308,879 |
| Stock Awards | $247,313 |
| Other | $12,679 |
| Total | $1,564,469 |
Muehl received $824.8K in option awards, accounting for 53% of the total pay in 2016.
Muehl also received $170.8K in bonus, $308.9K in salary, $247.3K in stock awards and $12.7K in other compensation.
Rankings
In 2016, Daniel W. Muehl's compensation ranked 6,053rd out of 14,075 executives tracked by ExecPay. In other words, Muehl earned more than 57.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,053 out of 14,075 | 57th |
Division Manufacturing | 2,204 out of 5,488 | 60th |
Major group Chemicals And Allied Products | 720 out of 1,900 | 62nd |
Industry group Drugs | 542 out of 1,543 | 65th |
Industry Pharmaceutical Preparations | 424 out of 1,173 | 64th |
Source: SEC filing on April 26, 2017.
Muehl's colleagues
We found five more compensation records of executives who worked with Daniel W. Muehl at Clovis Oncology in 2016.
2016
Lindsey Rolfe
Clovis Oncology
Chief Medical Officer
2016
Gillian Ivers-Read
Clovis Oncology
EVP of Technical Operations and Chief Regulatory Officer
2016
C Hooks
Clovis Oncology
Senior VP and Chief Commercial Officer
2016
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
2016
Erle Mast
Clovis Oncology
Chief Financial Officer
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019